New incubator board member
Thomas London has joined the board of Oslo Cancer Cluster Incubator.
This author has yet to write their bio.Meanwhile lets just say that we are proud oslocancer contributed a whooping 276 entries.
Thomas London has joined the board of Oslo Cancer Cluster Incubator.
How can manufacturing of T cell therapies be improved?
New data shows 27% improved survival in the NIPU trial.
Her er de viktigste sakene i Statsbudsjettet 2024 for Oslo Cancer Clusters medlemmer.